UK Approves ‘Ronapreve’ for Treatment of Coronavirus
The Medicines and Healthcare Products Regulatory Agency (MHRA) of United Kingdom has given the approval to Ronapreve, for the purpose of preventing the Infection and providing treatment to the symptoms of the severe disease, along with decreasing the likelihood of the hospitalization due to covid-19. This approval of Ronapreve has been followed by the data […]
Continue Reading